POST Online Media Lite Edition


NEWLY REPORTED COVID-19 CASES IN LAST 24 HOURS (9.24.2021, 6:35pm CEST, WHO):   U.S. 121,396    India 31,382    Brazil 36,473    United Kingdom 35,764    Russia 21,379    Turkey 27,844    France 5,433    Argentina 2,034    Columbia 1,581    Spain 1,056    Italy 4,053    Indonesia 2,557    Germany 9,727    Mexico 11,603    South Africa 2,783    Philippines 17,411    Ukraine 9,058    Malaysia 13,754    Netherlands 1,841    Iraq 2,953    Japan 3,457    Canada 3,870    Bangladesh 1,233    Thailand 12,697    Israel 6,314    Pakistan 2,357    Romania 7,116    Serbia 6,480    Cuba 6,935    Nepal 1,103    Vietnam 9,472    Austria 1,708    Greece 2,101    Georgia 1,698    Belarus 1,973    Costa Rica 2,547    Bulgaria 1,835    Azerbaijan 1,178    Myanmar 1,667    Croatia 1,291    Ireland 1,354    Venezuela 1,140    Ethiopia 1,544    Libya 1,006    Lithuania 1,477    South Korea 2,434    Mongolia 2,612    Slovenia 1,011    Moldova 1,215    Botswana 2,639    New Caledonia 1,078    China 65    Singapore 1,504    New Zealand 10    Australia 1,850   

Wuhan coronavirus: South Korea reviewing plans to import Japanese antiviral drug

Christian Fernsby |
Korea is developing a vaccine for the coronavirus while reviewing plans to import a Japanese antiviral drug to treat the growing number of people infected, officials said yesterday.

Article continues below


The Ministry of Food and Drug Safety said in a press briefing yesterday that it is considering a regulatory exemption for imports of Avigan, a drug made by Toyama Chemical and approved for treatment of influenza in 2014.

According to Japanese media outlets Tuesday, the drug showed effects in treating mild coronavirus cases in Japan.

They said the Japanese government is preparing to supply the drug across its own country within the next few days.

The coronavirus that spread from China doesn’t have a certified treatment nor vaccine as of yet.

As Avigan, or favipiravir, is not being imported to Korea at the moment, the Korean government has been using some forms of malaria and H.I.V. treatments to alleviate symptoms for some patients in Korea.

H.I.V. treatment Kaletra and malaria treatment hydroxychloroquine have alleviated pneumonia symptoms in more than 20 patients in Korea so far, according to the Korea Centers for Disease Control and Prevention and a number of hospitals.

The Ministry of Food and Drug Safety also said Korea has started developing a vaccine for the virus with the help of local companies and researchers.

What to read next

CDC raises Wuhan coronavirus travel alert, Hebei confirms first death outside epicentre
Three drugs fairly effective on Wuhan coronavirus on cellular level
2019-nCoV, extremely dangerous type of coronavirus that spreads fast